NasdaqGM - Nasdaq Real Time Price USD

BrainsWay Ltd. (BWAY)

Compare
9.50 +0.09 (+0.96%)
At close: October 11 at 4:00 PM EDT
9.64 +0.14 (+1.47%)
After hours: October 11 at 5:38 PM EDT
Loading Chart for BWAY
DELL
  • Previous Close 9.41
  • Open 9.79
  • Bid 9.38 x 100
  • Ask 9.53 x 100
  • Day's Range 9.41 - 9.74
  • 52 Week Range 3.09 - 10.00
  • Volume 40,577
  • Avg. Volume 90,806
  • Market Cap (intraday) 158.442M
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) 475.00
  • EPS (TTM) 0.02
  • Earnings Date Nov 13, 2024 - Nov 18, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 12.78

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

www.brainsway.com

134

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BWAY

View More

Performance Overview: BWAY

Trailing total returns as of 10/11/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BWAY
46.60%
TA-125
11.22%

1-Year Return

BWAY
139.29%
TA-125
17.99%

3-Year Return

BWAY
15.85%
TA-125
12.15%

5-Year Return

BWAY
5.56%
TA-125
35.94%

Compare To: BWAY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BWAY

View More

Valuation Measures

Annual
As of 10/11/2024
  • Market Cap

    161.80M

  • Enterprise Value

    116.28M

  • Trailing P/E

    475.00

  • Forward P/E

    52.91

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.42

  • Price/Book (mrq)

    3.69

  • Enterprise Value/Revenue

    3.19

  • Enterprise Value/EBITDA

    41.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.67%

  • Return on Assets (ttm)

    0.73%

  • Return on Equity (ttm)

    1.44%

  • Revenue (ttm)

    36.43M

  • Net Income Avi to Common (ttm)

    608k

  • Diluted EPS (ttm)

    0.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    47.86M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    3.16M

Research Analysis: BWAY

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 10.01M
Earnings 600k
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

10.00
12.78 Average
9.50 Current
16.00 High
 

Company Insights: BWAY

People Also Watch